Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A multicenter, open-label trial of ganaxolone in children with PCDH19 epilepsy
Epilepsy/Clinical Neurophysiology (EEG)
P5 - (-)
236
Authors/Disclosures
Jaakko Lappalainen, MD, PhD (Marinus)
PRESENTER
No disclosure on file
Michael Chez, MD, FAAN (Sutter Medical Group) Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ucb. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for marinus. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. Dr. Chez has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eiasai UCB Neurelis aquestiveGW. The institution of Dr. Chez has received research support from Marinus GW Eisai.
No disclosure on file
No disclosure on file
Nicola Specchio No disclosure on file
Albena I. Patroneva, MD (Harmony Biosciencesw) Dr. Patroneva has nothing to disclose.